propofol has been researched along with Diseases of Immune System in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, SC | 1 |
| Chung, PJ | 1 |
| Ho, CM | 1 |
| Kuo, CY | 1 |
| Hung, MF | 1 |
| Huang, YT | 1 |
| Chang, WY | 1 |
| Chang, YW | 1 |
| Chan, KH | 1 |
| Hwang, TL | 1 |
1 other study available for propofol and Diseases of Immune System
| Article | Year |
|---|---|
Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
Topics: Chemotaxis, Leukocyte; Humans; Hypnotics and Sedatives; Immune System Diseases; Immunoblotting; Leuk | 2013 |